Mahiro Yamamoto
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A five-factor risk-stratification model for cancer-associated myositis in idiopathic inflammatory myopathies and stage-specific survival analysis: a multicentre Japanese MYKO cohort study.
Journal: Frontiers in immunology
Published: June 21, 2026
Optimal glucocorticoid tapering in anti-synthetase syndrome-associated interstitial lung disease: A multicentre MYKO cohort study.
Journal: Modern rheumatology
Published: February 17, 2026
M-CSF, inducing CD163 macrophages, is associated with severity and prognosis of glomerulonephritis in microscopic polyangiitis.
Journal: Arthritis research & therapy
Published: July 24, 2025
Differences in Organ Damage Based on Age at Onset in Idiopathic Inflammatory Myopathies: A Retrospective Multicenter MYKO Study.
Journal: Internal medicine (Tokyo, Japan)
Published: May 14, 2025
Validation of the MCK model for predicting outcomes in myopathy-associated interstitial lung disease: a multicentre MYKO cohort study.
Journal: Modern rheumatology
Published: May 07, 2025
Risk prediction model for relapse of anti-synthetase syndrome-associated interstitial lung disease in Japanese multicentre MYKO cohort study.
Journal: Rheumatology (Oxford, England)
Published: March 15, 2025
Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply.
Journal: Rheumatology advances in practice
Published: March 18, 2022
Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report.
Journal: Rheumatology advances in practice
Published: November 17, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026